JPMorgan Chase & Co’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | – | – | 6406 |
|
|
2022
Q4 | $0 | Sell |
100
-8
| -7% | – | ﹤0.01% | 6321 |
|
|
2022
Q3 | $0 | Buy |
108
+8
| +8% | – | ﹤0.01% | 6150 |
|
|
2022
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 6239 |
|
|
2022
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 6267 |
|
|
2021
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 6218 |
|
|
2021
Q3 | $0 | Sell |
100
-6,407
| -98% | – | ﹤0.01% | 6001 |
|
|
2021
Q2 | $31K | Buy |
6,507
+4,607
| +242% | +$21.9K | ﹤0.01% | 5057 |
|
|
2021
Q1 | $10K | Sell |
1,900
-8,801
| -82% | -$46.3K | ﹤0.01% | 5034 |
|
|
2020
Q4 | $72K | Buy |
10,701
+7,740
| +261% | +$52.1K | ﹤0.01% | 4373 |
|
|
2020
Q3 | $29K | Buy |
2,961
+67
| +2% | +$656 | ﹤0.01% | 4425 |
|
|
2020
Q2 | $37K | Buy |
+2,894
| New | +$37K | ﹤0.01% | 4303 |
|
|
2018
Q3 | – | Sell |
-15,825
| Closed | -$574K | – | 4941 |
|
|
2018
Q2 | $574K | Buy |
15,825
+14,334
| +961% | +$520K | ﹤0.01% | 3388 |
|
|
2018
Q1 | $47K | Buy |
+1,491
| New | +$47K | ﹤0.01% | 4178 |
|